Foundry staff assisted scientists at UMass Medical School in the characterization of upconverting nanoparticles developed for potential clinical applications in photodynamic therapy, an approach that could kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy.
